@camiloliver.bsky.social
What to Know About the New H3N2 Flu Strain url: jamanetwork.com/journals/jam...
What to Know About the New H3N2 Flu Strain
This Medical News article discusses a new H3N2 influenza strain, called subclade K, that may lead to a more severe flu season.
jamanetwork.com
December 20, 2025 at 8:48 PM
What to Know About the New H3N2 Flu Strain url: jamanetwork.com/journals/jam...
UDCA and Cancer Risk for Patients With Primary Biliary Cholangitis url: jamanetwork.com/journals/jam...
UDCA and Cancer Risk for Patients With Primary Biliary Cholangitis
This cohort study uses electronic health record data to compare cancer incidence among adults with primary biliary cholangitis who were or were not treated with ursodeoxycholic acid (UDCA).
jamanetwork.com
December 20, 2025 at 8:47 PM
UDCA and Cancer Risk for Patients With Primary Biliary Cholangitis url: jamanetwork.com/journals/jam...
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D | New England Journal of Medicine www.nejm.org/doi/full/10....
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D | NEJM
Both tobevibart (a monoclonal antibody) and elebsiran (a small interfering RNA) target
hepatitis B virus surface antigen (HBsAg). Their efficacy and safety in the treatment
of chronic hepatitis D v...
www.nejm.org
November 10, 2025 at 3:18 AM
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D | New England Journal of Medicine www.nejm.org/doi/full/10....
Noninvasive Assessment of Liver Fibrosis | New England Journal of Medicine www.nejm.org/doi/full/10....
Noninvasive Assessment of Liver Fibrosis | NEJM
The prognosis of liver disease depends on the extent of fibrosis, which is usually
staged with the use of liver biopsy. The limitations of biopsy have led to the development
of noninvasive tests, w...
www.nejm.org
October 30, 2025 at 3:45 AM
Noninvasive Assessment of Liver Fibrosis | New England Journal of Medicine www.nejm.org/doi/full/10....
Butterfly Vertebra | New England Journal of Medicine www.nejm.org/doi/full/10....
Butterfly Vertebra | NEJM
In a 21-year-old woman who presented with a 7-day history of sore throat and cough, a chest radiograph showed two hemivertebrae at the ninth thoracic vertebral body.
www.nejm.org
October 9, 2025 at 1:53 AM
Butterfly Vertebra | New England Journal of Medicine www.nejm.org/doi/full/10....
Gut-brain nexus: Mapping multimodal links to neurodegeneration at biobank scale | Science Advances www.science.org/doi/10.1126/...
Gut-brain nexus: Mapping multimodal links to neurodegeneration at biobank scale
Co-occurring disorders of the gut-brain axis combined with genetic and proteomic data can better predict neurodegenerative risk.
www.science.org
August 28, 2025 at 9:07 PM
Gut-brain nexus: Mapping multimodal links to neurodegeneration at biobank scale | Science Advances www.science.org/doi/10.1126/...
Rat hepatitis E virus as an aetiological agent of acute hepatitis of unknown origin - Journal of Hepatology www.journal-of-hepatology.eu/article/S016...
Rat hepatitis E virus as an aetiological agent of acute hepatitis of unknown origin
Rat hepatitis E virus (ratHEV) is an emerging cause of acute hepatitis worldwide.
The limited number of ratHEV cases may be associated with the lack of a proper method
for molecular diagnosis; thus, t...
www.journal-of-hepatology.eu
August 15, 2025 at 8:56 PM
Rat hepatitis E virus as an aetiological agent of acute hepatitis of unknown origin - Journal of Hepatology www.journal-of-hepatology.eu/article/S016...
Metabolic Dysfunction–Associated Steatotic Liver Disease | New England Journal of Medicine www.nejm.org/doi/full/10....
Metabolic Dysfunction–Associated Steatotic Liver Disease | NEJM
MASLD has become the most common chronic liver disease worldwide. The authors review
the features of the disease as well as pharmacotherapies targeting the associated
liver and cardiovascular–renal–.....
www.nejm.org
August 14, 2025 at 4:57 AM
Metabolic Dysfunction–Associated Steatotic Liver Disease | New England Journal of Medicine www.nejm.org/doi/full/10....
Integrating Early Tuberculosis States Into Contact Management in Peru url:https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2837322?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=080725
August 7, 2025 at 9:21 PM
Integrating Early Tuberculosis States Into Contact Management in Peru url:https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2837322?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=080725
Alcohol and Cancer Risk url:https://jamanetwork.com/journals/jama/fullarticle/2837352?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=080725
August 7, 2025 at 9:19 PM
Alcohol and Cancer Risk url:https://jamanetwork.com/journals/jama/fullarticle/2837352?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=080725
Adverse Liver Outcomes, Cardiovascular Events, and Mortality in Steatotic Liver Disease url:https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2835432?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=061725
June 17, 2025 at 3:06 AM
Adverse Liver Outcomes, Cardiovascular Events, and Mortality in Steatotic Liver Disease url:https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2835432?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=061725
Reposted
🔥Nivolumab and Ipilimuma approved by EMA for advanced hepatocellular carcinoma 🔥
👇https://ec.europa.eu/health/documents/community-register/html/h1014.htm
👉great news for our patients > more options in 1st line
😅amazing: approval in 🇪🇺by EMA before 🇺🇸by FDA
@myESMO @EASLedu @ILCAnews #livertwitter
👇https://ec.europa.eu/health/documents/community-register/html/h1014.htm
👉great news for our patients > more options in 1st line
😅amazing: approval in 🇪🇺by EMA before 🇺🇸by FDA
@myESMO @EASLedu @ILCAnews #livertwitter
March 4, 2025 at 3:45 PM
🔥Nivolumab and Ipilimuma approved by EMA for advanced hepatocellular carcinoma 🔥
👇https://ec.europa.eu/health/documents/community-register/html/h1014.htm
👉great news for our patients > more options in 1st line
😅amazing: approval in 🇪🇺by EMA before 🇺🇸by FDA
@myESMO @EASLedu @ILCAnews #livertwitter
👇https://ec.europa.eu/health/documents/community-register/html/h1014.htm
👉great news for our patients > more options in 1st line
😅amazing: approval in 🇪🇺by EMA before 🇺🇸by FDA
@myESMO @EASLedu @ILCAnews #livertwitter
Reposted
🔗 Full paper: doi.org/10.1111/apt....
📝 Editorial by @reibergerthomas.bsky.social and Benedikt Simbrunner:
onlinelibrary.wiley.com/doi/epdf/10....
#LiverTwitter
📝 Editorial by @reibergerthomas.bsky.social and Benedikt Simbrunner:
onlinelibrary.wiley.com/doi/epdf/10....
#LiverTwitter
Clinical Trial: A Multicentre Randomised Controlled Trial of Carvedilol Versus Variceal Band Ligation in Primary Prevention of Variceal Bleeding in Liver Cirrhosis (CALIBRE Trial)
There is no evidence of a difference between carvedilol 12.5 mg daily and VBL in the primary prevention of variceal bleeding in patients with cirrhosis and medium-to large-sized oesophageal varices. ....
doi.org
May 9, 2025 at 3:06 PM
🔗 Full paper: doi.org/10.1111/apt....
📝 Editorial by @reibergerthomas.bsky.social and Benedikt Simbrunner:
onlinelibrary.wiley.com/doi/epdf/10....
#LiverTwitter
📝 Editorial by @reibergerthomas.bsky.social and Benedikt Simbrunner:
onlinelibrary.wiley.com/doi/epdf/10....
#LiverTwitter